BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 1, 1998
View Archived Issues
Northwest Biotherapeutics patents dendritic cell-based immunotherapy for prostate cancer
Read More
Androsorb to enter second part of hormone replacement therapy trial
Read More
RiboGene and EnzyMed to collaborate on antiinfective drug discovery
Read More
American Biogenetic Sciences and the University of Maryland to develop HHV-8 diagnostic test
Read More
Unique asthma medication launched in Canada
Read More
More alpha2-adrenoceptor agonists in the pipeline at Procter & Gamble
Read More
Boehringer Mannheim reports new discovery in cancer research
Read More
Targeted Genetics: Q2 1998 highlights
Read More
Vical: Q2 1998 highlights
Read More
Microencapsulated aspirin is a good alternative for treatment of atherosclerosis
Read More
Prolifix and BioFocus to cooperate on cancer drug development
Read More
Less incidence of overt heart failure in myocardial infarction patients receiving aspirin
Read More
Ciclosporin oral solution dispenser cleared by the FDA for marketing
Read More
Aspirin-induced increase in ferritin synthesis prevents oxidative injury in cardiovascular disease
Read More
Access signs development agreement with ViroTex for amlexanox formulations
Read More
Cheil Jedang discloses PDE IV inhibitors for treating asthma
Read More
New anticancer agents discovered at American Cyanamid
Read More
Chugai investigates macrolide compounds as prokinetic agents
Read More
Novel agents for irritable bowel syndrome in early development at Kyorin
Read More
Mylan acquires U.S. marketing rights to Zagam
Read More
GeneMedicine receives patent protection for gene delivery technologies
Read More
ProScript team describes novel Ras endoprotease inhibitor at ACS meeting
Read More
PD-165167 shows excellent selectivity for dopamine D4 receptors
Read More
Novo Nordisk describes the first nonpeptide competitive glucagon antagonist
Read More
Profile of TI-138067, a novel tubulin inhibitor in phase I testing
Read More
Novartis continues to study DPP IV inhibitors; new lead reported at ACS meeting
Read More
News from the ACS: Btk inhibitor LFM-A13 promotes apoptosis in leukemia cells
Read More
Orphan drug designation granted for thalidomide in KS
Read More
FDA approves first vaccine for prevention of rotaviral disease
Read More
